PMcardio is an advanced medical device powered by artificial intelligence (AI) that significantly enhances the diagnosis and treatment of cardiovascular diseases. As a certified class IIb medical device, it utilizes image recognition technology to digitize and reconstruct 12-lead ECGs, providing accurate and comprehensive insights to healthcare professionals.

Key Features:

1. Image Recognition Technology: Digitize and reconstruct 12-lead ECGs for accurate diagnosis.
2. Diagnose 38 Cardiovascular Diseases: Accurately identify and diagnose various cardiovascular conditions.
3. Treatment Recommendations: Provide treatment recommendations based on patient parameters and clinical practice guidelines.
4. Detailed ECG Diagnostic Reports: Create comprehensive reports by entering patient parameters and answering clinical questions.
5. Collaboration and Consultation: Share reports with colleagues and consult within the app for enhanced patient management.
6. Export Functionality: Export reports for further analysis or archiving purposes.
7. Exceptional Performance: Demonstrated improvement in arrhythmia and heart attack detection, as well as diagnostic precision.

Use Cases:

• Cardiovascular Disease Diagnosis: Accurately diagnose various cardiovascular conditions using digitized ECGs.
• Treatment Recommendation: Receive treatment recommendations based on clinical practice guidelines and patient parameters.
• Collaboration and Consultation: Share ECG reports with colleagues for collaborative decision-making and consultation.
• Remote Diagnosis: Facilitate remote diagnosis of cardiovascular diseases using AI-powered ECG analysis.
• Healthcare Efficiency: Improve diagnostic accuracy and treatment efficiency to enhance patient care.

PMcardio revolutionizes cardiovascular disease diagnosis and treatment by leveraging AI-powered image recognition technology. With its accurate diagnoses, treatment recommendations, and collaboration features, PMcardio empowers healthcare professionals to deliver exceptional care and improve patient outcomes.